Latest Breaking News On - Intellomx director dr simon - Page 1 : comparemela.com

Intellomx have received Chinese government approval for a novel clinical diagnostics study for TB, to distinguish patients with latent TB using biomarkers.

United kingdomSimon haworthXianxiang chenMinistry of science technologyWorld health organisationIntellomx corporateWuhan pulmonarySino united kingdomWuhan pulmonary hospitalHuman genetic resources administrative licensingIntellomx director dr simonUnited kingdom basedKnowledge graphs